close
MENU
Hot Topic Hawke’s Bay
Hot Topic Hawke’s Bay
Investment
4 mins to read

Rua Bioscience: Ditching manufacturing was a logical move

The company has been exploring where true value lies in the medicinal cannabis industry.

Gisborne-based NZX-listed medicinal cannabis company Rua Bioscience says walking away from local product manufacturing was a logical business move, albeit tough on its people.

The company made the decision to revamp its corporate strategy in March, when it announced it would ditch GMP (good

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Nicholas Pointon Wed, 11 Oct 2023
Contact the Writer: nicholas@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
Rua Bioscience: Ditching manufacturing was a logical move
Investment,
101201
true